Cargando…
A map of metabolic phenotypes in patients with myalgic encephalomyelitis/chronic fatigue syndrome
Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a debilitating disease usually presenting after infection. Emerging evidence supports that energy metabolism is affected in ME/CFS, but a unifying metabolic phenotype has not been firmly established. We performed global metabolomics, lip...
Autores principales: | Hoel, Fredrik, Hoel, August, Pettersen, Ina K.N., Rekeland, Ingrid G., Risa, Kristin, Alme, Kine, Sørland, Kari, Fosså, Alexander, Lien, Katarina, Herder, Ingrid, Thürmer, Hanne L., Gotaas, Merete E., Schäfer, Christoph, Berge, Rolf K., Sommerfelt, Kristian, Marti, Hans-Peter, Dahl, Olav, Mella, Olav, Fluge, Øystein, Tronstad, Karl J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Clinical Investigation
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8409979/ https://www.ncbi.nlm.nih.gov/pubmed/34423789 http://dx.doi.org/10.1172/jci.insight.149217 |
Ejemplares similares
-
Activity monitoring and patient-reported outcome measures in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome patients
por: Rekeland, Ingrid G., et al.
Publicado: (2022) -
Intravenous Cyclophosphamide in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. An Open-Label Phase II Study
por: Rekeland, Ingrid G., et al.
Publicado: (2020) -
B-Lymphocyte Depletion in Myalgic Encephalopathy/ Chronic Fatigue Syndrome. An Open-Label Phase II Study with Rituximab Maintenance Treatment
por: Fluge, Øystein, et al.
Publicado: (2015) -
Reduced Endothelial Function in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome–Results From Open-Label Cyclophosphamide Intervention Study
por: Sørland, Kari, et al.
Publicado: (2021) -
Endothelial dysfunction in ME/CFS patients
por: Sandvik, Miriam Kristine, et al.
Publicado: (2023)